| CAS NO: | 112143-77-8 |
| 包装: | 50mg, 100mg, 250mg |
| 规格: | ≥98% |
Khardin is a bioactive compound. References: Gordon KB, Colombel JF, Hardin DS. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med. 2016 Nov 24;375(21):2102. doi: 10.1056/NEJMc1610828. PubMed PMID: 27959738.
纯度：≥98%
CAS：112143-77-8
m.cnreagent.com